ONCHOCERCIASIS
Clinical trials for ONCHOCERCIASIS explained in plain language.
Never miss a new study
Get alerted when new ONCHOCERCIASIS trials appear
Sign up with your email to follow new studies for ONCHOCERCIASIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Twice-Yearly drug could beat river blindness
Disease control OngoingThis study tests if taking moxidectin twice a year is safer and more effective than once a year for treating river blindness, a parasitic disease. About 323 people in the Democratic Republic of Congo will receive either moxidectin or ivermectin annually or biannually. The goal is…
Matched conditions: ONCHOCERCIASIS
Phase: PHASE3 • Sponsor: Medicines Development for Global Health • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
New drug cocktails aim to beat river blindness
Disease control OngoingThis study tests four different drug combinations in 300 adults with onchocerciasis (river blindness), a parasitic disease. Participants first receive ivermectin to clear skin and eye parasites, then get one of the new combos. The goal is to see which combo is safest and most eff…
Matched conditions: ONCHOCERCIASIS
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC